Survival and medical costs of non-small cell lung cancer patients according to the first-line treatment: An observational study using the Kyoto City Integrated Database.
Tomonari ShimamotoYukiko TateyamaDaisuke KobayashiKeiichi YamamotoYoshimitsu TakahashiHiroaki UeshimaKosuke SasakiTakeo NakayamaTaku IwamiPublished in: Thoracic cancer (2023)
As a first-line therapy in newly diagnosed patients with NSCLC, surgical resection is associated with longer survival and lower medical costs than pharmacotherapy or radiotherapy.
Keyphrases
- newly diagnosed
- end stage renal disease
- healthcare
- small cell lung cancer
- chronic kidney disease
- ejection fraction
- radiation therapy
- peritoneal dialysis
- cell therapy
- advanced non small cell lung cancer
- free survival
- bone marrow
- mesenchymal stem cells
- locally advanced
- squamous cell carcinoma
- patient reported outcomes
- radiation induced
- rectal cancer
- tyrosine kinase
- epidermal growth factor receptor